VIRGINIA COMMONWEALTH UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 10K

Market Cap: -

Website: http://www.vcu.edu

Clinical Trials

Use of Methacetin Breath Test to Predict Liver Failure in Patients With Cirrhosis

Phase 3

Completed

Conditions: Cirrhosis

Interventions: Device: BreathID (Methacetin breath test)

First Posted Date: 2010-07-07

Last Posted Date: 2014-05-16

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 165

Registration Number: NCT01157845

Locations: 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States
🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
🇮🇱
Hadassah Medical Center, Jerusalem, Israel

and more 1 locations

Flail Chest - Rib Fixation Study

Not Applicable

Terminated

Conditions: Flail Chest

Interventions: Device: operative rib fixation
Procedure: operative rib fixation surgery

First Posted Date: 2010-06-22

Last Posted Date: 2015-08-06

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 24

Registration Number: NCT01147471

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
🇺🇸
The University of Tennessee, Knoxville, Tennessee, United States

and more 4 locations

Use of Laryngeal Mask Airway in Pediatric Adenotonsillectomy

Not Applicable

Completed

Conditions: Tonsillectomy
Laryngeal Mask Airway

Interventions: Device: Endotracheal Tube
Device: Laryngeal mask airway

First Posted Date: 2010-06-10

Last Posted Date: 2017-11-13

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 131

Registration Number: NCT01141660

Locations: 🇺🇸
Virigina Commonwealth University Medical Center, Richmond, Virginia, United States

The Causes and Interpretation of Low-level Resistance in Staphylococcus Aureus

Completed

Conditions: Staphylococcus Aureus

First Posted Date: 2010-05-21

Last Posted Date: 2014-07-09

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 45

Registration Number: NCT01127516

Locations: 🇺🇸
Virginia Commonwealth University School ofPharamcy, Richmond, Virginia, United States

Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer

Not Applicable

Completed

Conditions: Adenocarcinoma of the Prostate
Stage II Prostate Cancer
Stage IV Prostate Cancer
Stage I Prostate Cancer
Stage III Prostate Cancer

Interventions: Radiation: intensity modulated external beam radiation therapy

First Posted Date: 2010-05-06

Last Posted Date: 2019-06-28

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 55

Registration Number: NCT01117935

Locations: 🇺🇸
Hunter Holmes McGuire Veterans Administration Medical Center, Richmond, Virginia, United States
🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States

Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia

Not Applicable

Completed

Conditions: Hemophilia A
Hemophilia B
Vitamin D Deficiency

Interventions: Dietary Supplement: Vitamin D and calcium

First Posted Date: 2010-03-19

Last Posted Date: 2016-04-29

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 20

Registration Number: NCT01090206

Locations: 🇺🇸
Virginia Commonwealth University Health System, Richmond, Virginia, United States

Antimicrobial Drug Use and Resistant Staphylococcus Aureus

Completed

Conditions: Staphylococcus Aureus

First Posted Date: 2010-02-25

Last Posted Date: 2013-05-20

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 41

Registration Number: NCT01075451

Locations: 🇺🇸
Virginia Commonwealth University School ofPharamcy, Richmond, Virginia, United States

Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome

Phase 1

Completed

Conditions: Acute Lymphocytic Leukemia
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Chronic Myelogenous Leukemia

Interventions: Drug: bortezomib
Drug: belinostat
Other: laboratory biomarker analysis
Genetic: western blotting
Other: pharmacological study
Other: flow cytometry

First Posted Date: 2010-02-25

Last Posted Date: 2016-04-15

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 41

Registration Number: NCT01075425

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer

Phase 1

Completed

Conditions: Liver Cancer

Interventions: Drug: sorafenib tosylate
Drug: vorinostat

First Posted Date: 2010-02-24

Last Posted Date: 2019-08-20

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 16

Registration Number: NCT01075113

Locations: 🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States
🇺🇸
Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, United States

Predictors of Rates of Resistant Gram-Negative Bacteria

Completed

Conditions: Relationship of Carbapenem Use to Carbapenem Resistant Gram-negative Bacteria

First Posted Date: 2010-02-24

Last Posted Date: 2014-07-09

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 36

Registration Number: NCT01075009

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy